|
Market Closed -
Bombay S.E.
06:02:23 2026-08-21 EDT
|
5-day change | 1st Jan Change | ||
| 32.24 INR | +0.19% |
|
-5.15% | -32.35% |
| Market Cap | 976M 10.2M 8.74M 8.17M 7.48M 14.04M 14.23M 96.58M 37.66M 490M 38.3M 37.46M 1.62B | P/E 2024 |
-14.8x | P/E 2025 | -22.5x |
|---|---|---|---|---|---|
| Enterprise Value | 1.34B 14.05M 12.03M 11.26M 10.31M 19.34M 19.6M 133M 51.88M 675M 52.75M 51.6M 2.23B | EV / Sales 2024 |
12,382,225x | EV / Sales 2025 | 14,347,129x |
| Free-Float |
25.74% | Yield 2024 * |
-
| Yield 2025 | - |
| 1 day | +0.19% | ||
| 1 week | -5.15% | ||
| Current month | +4.00% | ||
| 1 month | +4.03% | ||
| 3 months | +9.85% | ||
| 6 months | -7.96% | ||
| Current year | -32.35% |
| 1 week | 31.2 | 34.79 | |
| 1 month | 29.5 | 36.8 | |
| Current year | 25.6 | 50.9 | |
| 1 year | 25.6 | 66 | |
| 3 years | 25.6 | 87.46 | |
| 5 years | 10.17 | 87.46 | |
| 10 years | 2.15 | 87.46 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Director of Finance/CFO | - | 2022-10-12 | |
| Chief Tech/Sci/R&D Officer | - | 2025-08-06 | |
| Compliance Officer | - | 2024-08-13 |
| Director | Title | Age | Since |
|---|---|---|---|
Mini Manikantan
BRD | Director/Board Member | - | 2022-07-08 |
| Director/Board Member | - | - | |
| Chairman | 75 | 2025-12-04 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +0.19% | -5.15% | -48.13% | -12.34% | 11.86M | ||
| +0.88% | +3.84% | +77.96% | +129.75% | 1,109B | ||
| +1.07% | +3.11% | +51.11% | +56.67% | 644B | ||
| +1.20% | +5.64% | +26.68% | +76.48% | 463B | ||
| +1.02% | +3.67% | +43.14% | +47.27% | 371B | ||
| +0.85% | +2.97% | +24.48% | +42.54% | 301B | ||
| +1.26% | +4.54% | +2.20% | +14.84% | 256B | ||
| +1.88% | +5.14% | +48.20% | +67.80% | 234B | ||
| +1.59% | +0.87% | -12.95% | -51.91% | 205B | ||
| +1.87% | +5.78% | +23.07% | +92.57% | 178B | ||
| Average | +1.06% | +2.40% | +23.58% | +46.37% | 376.11B | |
| Weighted average by Cap. | +1.06% | +3.38% | +44.79% | +72.24% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 151.12 1.58 1.35 1.27 1.16 2.17 2.2 14.96 5.83 75.92 5.93 5.8 251.1 | 194.47 2.03 1.74 1.63 1.49 2.8 2.84 19.25 7.51 97.69 7.63 7.47 323.13 |
| Net income | -79.68M -833K -713K -667K -611K -1.15M -1.16M -7.89M -3.08M -40.03M -3.13M -3.06M -132M | -108M -1.13M -965K -903K -826K -1.55M -1.57M -10.67M -4.16M -54.14M -4.23M -4.14M -179M |
| Net Debt | 37.29M 390K 334K 312K 286K 537K 544K 3.69M 1.44M 18.73M 1.46M 1.43M 61.96M | 368M 3.85M 3.3M 3.09M 2.82M 5.3M 5.37M 36.45M 14.21M 185M 14.45M 14.14M 612M |
Employees
28
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-08-21 | ₹32.24 | +0.19% | 3,197 |
| 26-08-20 | ₹32.18 | -2.48% | 2,485 |
| 26-08-19 | ₹33.00 | +0.03% | 1,666 |
| 26-08-18 | ₹32.99 | -1.20% | 3,332 |
| 26-08-17 | ₹33.39 | -0.15% | 4,647 |
- Stock Market
- Stocks
- PHARMAID Stock
Select your edition
All financial news and data tailored to specific country editions
















